Navigation Links
Hospital gives first tomosynthesis mammograms in region this week

There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & infants Hospital of Rhode Island has taken the breast cancer battle to the next level with the installation of the most advanced imaging technology available, called digital breast tomosynthesis.

Women & Infants is the first and only facility in southeastern New England to offer this new technology, which was approved in February 2011 by the federal Food and Drug Administration (FDA). The first woman to receive a digital tomosynthesis test in the region was processed at the hospital yesterday.

Digital breast tomosynthesis captures three-dimensional images of the breast versus the two-dimensional ones available through standard full-field digital mammography. This gives a more comprehensive and clear image for the radiologist to interpret, increases the early detection rate for breast cancer by up to 15%, and decreases the number of false positive findings by about 25%.

"Tomosynthesis gives doctors a clearer view of a woman's breast tissue and significantly helps us screen for and find potential breast cancers," explained Patricia Spencer, MD, chief of the Department of Diagnostic Imaging at Women & Infants.

The new technology is used at the same time the technologist conducts a routine digital mammography, which is still considered the "gold standard" in breast imaging. However, the two-dimensional digital mammography takes an image of the entire breast in one exposure, which means features of the breast can be hidden by overlapping tissue.

Tomosynthesis takes images from multiple angles and uses computer processing to compile them into a three-dimensional picture a radiologist can examine and manipulate. The added detail helps the radiologist pinpoint the size, location and shape of any breast abnormality, and can help distinguish real tumors from harmless abnormalities. Because digital breast tomosynthesis removes the layers of breast structure and tissue, it is particularly beneficial for women with dense breasts.

"The result is fewer calls to patients for further testing and less overall anxiety for women," Dr. Spencer said. Even though in 2010, the U.S. Preventive Services Task Force recommended screening every two years for women ages 50 to 74, the American Cancer Society still recommends annual screening for all women age 40 and older. Women & Infants adheres to the American Cancer Society recommendations, believing the best chance for survival and cure is early detection. This is the hospital's motivation for bringing the advanced technology of digital breast tomosynthesis to the women of Rhode Island and southeastern New England.

Contact: Susan McDonald
Women & Infants Hospital

Related medicine news :

1. The private sale of drugs in public hospitals
2. Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007
3. Launches Unique Eco-friendly Seating for Health Care, Hospitality, Assisted Living Centers, and Home Use at Competitive Prices
4. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
5. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
6. American Heart Association Comment on Hospitalization of President Bill Clinton
7. Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment
8. SHARECOR Partners With Quantros, Inc. to Facilitate Core Measures and Regulatory Reporting in Louisiana Hospitals
9. Kaiser Foundation Health Plan and Hospitals Report Fourth Quarter and Fiscal Year 2009 Financial Results
10. Father Channels His Grief into Advocacy, Promotes Simple Actions to Make Hospitals Safer for Children
11. Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince
Post Your Comments:
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017   Divoti USA will ... to the standard of the latest FDA requirements, which stipulates new ... Anyone in need of Medical ID jewelry such as Medical ... are engraved in terms of the new FDA requirements ... Divoti offers this dark ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
Breaking Medicine Technology: